TTR mouse Monoclonal Antibody(5A11)

This gene encodes transthyretin, one of the three prealbumins including alpha-1-antitrypsin, transthyretin and orosomucoid. Transthyretin is a carrier protein; it transports thyroid hormones in the plasma and cerebrospinal fluid, and also transports retinol (vitamin A) in the plasma. The protein consists of a tetramer of identical subunits. More than 80 different mutations in this gene have been reported; most mutations are related to amyloid deposition, affecting predominantly peripheral nerve and/or the heart, and a small portion of the gene mutations is non-amyloidogenic. The diseases caused by mutations include amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis, carpal tunnel syndrome, etc.

Introducing the TTR Mouse Monoclonal Antibody (5A11), a cutting-edge product designed to revolutionize the field of biomedical research. This highly specialized antibody is meticulously crafted to target and detect Transthyretin (TTR), a protein of significant interest in various pathological conditions.

The TTR Mouse Monoclonal Antibody (5A11) boasts exceptional specificity and sensitivity, enabling researchers to accurately identify and quantify TTR in biological samples. Its superior performance is attributed to the advanced hybridoma technology employed during its development, ensuring the production of a highly pure and reliable antibody.

With its remarkable affinity for TTR, this antibody offers an invaluable tool for investigating the role of TTR in disease progression, as well as for monitoring therapeutic interventions. Its application extends to a wide range of research areas, including neurodegenerative disorders, cardiovascular diseases, and amyloidosis.

The TTR Mouse Monoclonal Antibody (5A11) is supplied in a convenient and user-friendly format, facilitating seamless integration into laboratory workflows. Its exceptional stability and long shelf life guarantee consistent and reproducible results, making it an indispensable asset for any research endeavor.

In summary, the TTR Mouse Monoclonal Antibody (5A11) represents a breakthrough in the field of biomedical research, offering unparalleled specificity, sensitivity, and reliability. By harnessing the power of this innovative antibody, researchers can unlock new insights into the intricate mechanisms underlying various pathological conditions, ultimately paving the way for novel diagnostic and therapeutic strategies.